AI and Machine Learning-Driven Precision Diagnosis and Treatment for Parkinson's Disease and Related Disorders: A Systematic Review of Quantitative Ultrasound Imaging, Personalized Treatment Strategies, and Adaptive Deep Brain Stimulation
Aug 2026· International Conference Computational Vision and Bio Inspired Computing· pp. 1-9· 0 citations· 18 references
Abstract
Parkinson's disease (PD) and related illnesses can now be better detected and treated because to recent developments in artificial intelligence (AI) and machine learning (ML). PD is a degenerative neurological condition that profoundly impairs both motor and non-motor function, making prompt diagnosis and effective treatment difficult. This systematic review focuses on the examination of the recent literature (2023-2026) in which the authors consider different aspects of the application of AI for detection and therapy of the condition in question through diverse data modalities such as medical imaging, speech signals, clinical biomarkers, and electrophysiology. It has been found that more sophisticated ML algorithms such as deep learning, ensemble learning, and multimodal fusion contribute to improvement in the accuracy of diagnostics. Adaptive Deep Brain Stimulation (aDBS) has also been examined as a prospective solution to provide personalized treatment by allowing controlling the parameters of stimulation in real time. At the same time, certain challenges related to limitations in datasets, interpretability and clinical validation have not been overcome yet.
Multimodal fusion architectures, particularly cross-attention transformers integrating motor, voice, and gait data, consistently outperformed unimodal approaches by 4%-8% in the area under the receiver operating characteristic curve (AUC), with the largest gains in early stage detection and differential diagnosis tasks...
Muhammad Imran Khan, A. Imran, A. Alshammari· Computational biology and ch...· 0 citations
The timely identification of Alzheimer’s Disease (AD) is crucial for the provision of adequate treatment to the patients. The traditional diagnostic techniques such as neuroimaging, CSF examination, and neuropsychological testing might be relatively expensive, invasive, and sensitive. Due to the development of Artifici...
Prof. Minak K, Chinthan G K, Indrajith P, Lakshmi C. Mudur Krutika R Budni· International Journal of Adv...· 0 citations
Parkinson's disease (PD) demands both accurate early diagnosis and reliable assessment of progression, yet its clinical manifestations are heterogeneous and often become evident only after substantial neurodegeneration has occurred. This paper investigates whether multimodal artificial intelligence (AI) can address the...
Ravikumar Mutyala· Natural Resources for Human...· 0 citations
Aim: This study aimed to evaluate the early diagnostic potential of subthalamic nucleus (STN) radiomic features and machine learning algorithms to differentiate Parkinson's disease patients requiring Deep Brain Stimulation (DBS) from those managed solely with medical therapy. This approach seeks to provide a non-invasi...
C. Tonge, M. Eşmekaya, O. Inam et al.· Turkish Journal of Clinical...· 0 citations
Neurological disorders like Alzheimer’s disease, Parkinson’s disease, and epilepsy are becoming major causes of disability and mortality worldwide, and their prevalence is expected to rapidly increase with the aging of the population. These diseases develop silently, with irreversible neuronal damage often occurring de...
A. Rahmani, Tarique Sarwar· Diagnostics· 0 citations
Overall, current AI systems remain highly dependent on existing datasets and heterogeneous evaluation protocols, which limit generalizability and clinical applicability, and future research should prioritize representative multimodal datasets, rigorous external validation, and clinically interpretable AI systems.
José Menezes, M. I. Barbosa, P. M. Rodrigues· Italian National Conference...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.